{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T13:44:43Z","timestamp":1769089483598,"version":"3.49.0"},"reference-count":273,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"NCI","doi-asserted-by":"publisher","award":["P01 CA217798"],"award-info":[{"award-number":["P01 CA217798"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"NCI","doi-asserted-by":"publisher","award":["R01CA195586"],"award-info":[{"award-number":["R01CA195586"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"NCI","doi-asserted-by":"publisher","award":["R01CA218545"],"award-info":[{"award-number":["R01CA218545"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"NCI","doi-asserted-by":"publisher","award":["R01CA241752"],"award-info":[{"award-number":["R01CA241752"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"NCI","doi-asserted-by":"publisher","award":["R01CA247471"],"award-info":[{"award-number":["R01CA247471"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Cancer Biology"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.semcancer.2021.12.009","type":"journal-article","created":{"date-parts":[[2021,12,27]],"date-time":"2021-12-27T02:05:06Z","timestamp":1640570706000},"page":"914-930","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"P3","title":["Rethinking the chemokine cascade in brain metastasis: Preventive and therapeutic implications"],"prefix":"10.1016","volume":"86","author":[{"given":"Shailendra Kumar","family":"Maurya","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8566-0248","authenticated-orcid":false,"given":"Parvez","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asad Ur","family":"Rehman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ranjana K.","family":"Kanchan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naveenkumar","family":"Perumal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2483-0610","authenticated-orcid":false,"given":"Sidharth","family":"Mahapatra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0574-9307","authenticated-orcid":false,"given":"Hitendra S.","family":"Chand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6132-7328","authenticated-orcid":false,"given":"Juan A.","family":"Santamaria-Barria","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Surinder K.","family":"Batra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohd Wasim","family":"Nasser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.semcancer.2021.12.009_bib0005","first-page":"5","article-title":"Metastatic brain tumors","volume":"73","author":"Shirahata","year":"2021","journal-title":"Brain Nerve"},{"issue":"9","key":"10.1016\/j.semcancer.2021.12.009_bib0010","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.15444","article-title":"Association of immunotherapy with survival among patients with brain metastases whose Cancer Was managed with definitive surgery of the primary tumor","volume":"3","author":"Amin","year":"2020","journal-title":"JAMA Netw. Open"},{"issue":"1","key":"10.1016\/j.semcancer.2021.12.009_bib0015","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/s41572-019-0061-8","article-title":"Brain metastases","volume":"5","year":"2019","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"3","key":"10.1016\/j.semcancer.2021.12.009_bib0020","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.trecan.2018.01.003","article-title":"The evolving landscape of brain metastasis","volume":"4","author":"Valiente","year":"2018","journal-title":"Trends Cancer"},{"issue":"1","key":"10.1016\/j.semcancer.2021.12.009_bib0025","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1007\/s11912-011-0203-y","article-title":"Epidemiology of brain metastases","volume":"14","author":"Nayak","year":"2012","journal-title":"Curr. Oncol. Rep."},{"key":"10.1016\/j.semcancer.2021.12.009_bib0030","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/B978-0-12-811161-1.00002-5","article-title":"Brain metastases: epidemiology","volume":"149","author":"Ostrom","year":"2018","journal-title":"Handb. Clin. Neurol."},{"issue":"3","key":"10.1016\/j.semcancer.2021.12.009_bib0035","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1158\/0008-5472.CAN-18-1805","article-title":"A blazing landscape: neuroinflammation shapes brain metastasis","volume":"79","author":"Doron","year":"2019","journal-title":"Cancer Res."},{"issue":"8","key":"10.1016\/j.semcancer.2021.12.009_bib0040","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/nrc865","article-title":"Dissemination and growth of cancer cells in metastatic sites","volume":"2","author":"Chambers","year":"2002","journal-title":"Nat. Rev. Cancer"},{"issue":"8","key":"10.1016\/j.semcancer.2021.12.009_bib0045","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1038\/nm1469","article-title":"Tumor metastasis: mechanistic insights and clinical challenges","volume":"12","author":"Steeg","year":"2006","journal-title":"Nat. Med."},{"issue":"1\u20132","key":"10.1016\/j.semcancer.2021.12.009_bib0050","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.imlet.2009.12.003","article-title":"Chemokine-chemokine receptor axes in melanoma brain metastasis","volume":"130","author":"Izraely","year":"2010","journal-title":"Immunol. Lett."},{"issue":"11","key":"10.1016\/j.semcancer.2021.12.009_bib0055","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1093\/neuonc\/noy044","article-title":"Breast cancer brain metastasis: molecular mechanisms and directions for treatment","volume":"20","author":"Pedrosa","year":"2018","journal-title":"Neuro Oncol"},{"issue":"12","key":"10.1016\/j.semcancer.2021.12.009_bib0060","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1158\/2326-6066.CIR-14-0160","article-title":"Chemokines in cancer","volume":"2","author":"Chow","year":"2014","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.semcancer.2021.12.009_bib0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/112_2020_35","article-title":"CXC chemokine receptors in the tumor microenvironment and an update of antagonist development","volume":"178","author":"Xun","year":"2020","journal-title":"Rev. Physiol. Biochem. Pharmacol."},{"issue":"12","key":"10.1016\/j.semcancer.2021.12.009_bib0070","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.18632\/oncotarget.1426","article-title":"Chemokines in tumor progression and metastasis","volume":"4","author":"Sarvaiya","year":"2013","journal-title":"Oncotarget"},{"key":"10.1016\/j.semcancer.2021.12.009_bib0075","doi-asserted-by":"crossref","DOI":"10.1007\/s10555-021-09970-6","article-title":"Chemokines orchestrate tumor cells and the microenvironment to achieve metastatic heterogeneity","author":"Saxena","year":"2021","journal-title":"Cancer Metastasis Rev."},{"issue":"4","key":"10.1016\/j.semcancer.2021.12.009_bib0080","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1097\/PPO.0000000000000126","article-title":"The biology of brain metastasis: challenges for therapy","volume":"21","author":"Fidler","year":"2015","journal-title":"Cancer J."},{"issue":"8","key":"10.1016\/j.semcancer.2021.12.009_bib0085","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1093\/neuonc\/noaa013","article-title":"Subtype switching in breast cancer brain metastases: a multicenter analysis","volume":"22","author":"Hulsbergen","year":"2020","journal-title":"Neuro Oncol"},{"issue":"4","key":"10.1016\/j.semcancer.2021.12.009_bib0090","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/s41588-020-0592-7","article-title":"Genomic characterization of human brain metastases identifies drivers of metastatic lung adenocarcinoma","volume":"52","author":"Shih","year":"2020","journal-title":"Nat. Genet."},{"key":"10.1016\/j.semcancer.2021.12.009_bib0095","doi-asserted-by":"crossref","first-page":"230","DOI":"10.3389\/fonc.2017.00230","article-title":"Genetic characterization of brain metastases in the era of targeted therapy","volume":"7","author":"Han","year":"2017","journal-title":"Front. Oncol."},{"issue":"12","key":"10.1016\/j.semcancer.2021.12.009_bib0100","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22126336","article-title":"Inter-metastatic heterogeneity of tumor marker expression and microenvironment architecture in a preclinical Cancer model","volume":"22","author":"Kalra","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"28","key":"10.1016\/j.semcancer.2021.12.009_bib0105","doi-asserted-by":"crossref","first-page":"5566","DOI":"10.1038\/s41388-019-0832-4","article-title":"Cancer extracellular vesicles contribute to stromal heterogeneity by inducing chemokines in cancer-associated fibroblasts","volume":"38","author":"Naito","year":"2019","journal-title":"Oncogene"},{"issue":"12","key":"10.1016\/j.semcancer.2021.12.009_bib0110","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21124449","article-title":"Cytokines and chemokines as mediators of prostate Cancer metastasis","volume":"21","author":"Adekoya","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.semcancer.2021.12.009_bib0115","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1631\/jzus.B1500258","article-title":"Chemokines and their receptors in lung cancer progression and metastasis","volume":"17","author":"Cheng","year":"2016","journal-title":"J. Zhejiang Univ. Sci. B"},{"key":"10.1016\/j.semcancer.2021.12.009_bib0120","doi-asserted-by":"crossref","first-page":"335","DOI":"10.3389\/fonc.2020.00335","article-title":"The endosteal niche in breast Cancer bone metastasis","volume":"10","author":"Haider","year":"2020","journal-title":"Front. Oncol."},{"issue":"4","key":"10.1016\/j.semcancer.2021.12.009_bib0125","doi-asserted-by":"crossref","first-page":"3376","DOI":"10.1002\/jcp.27305","article-title":"Signaling-chemokine axis network in brain as a sanctuary site for metastasis","volume":"234","author":"Azizidoost","year":"2019","journal-title":"J. Cell. Physiol."},{"issue":"17","key":"10.1016\/j.semcancer.2021.12.009_bib0130","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.4161\/cbt.8.17.9202","article-title":"CXCL12, CXCR4 and CXCR7 expression in brain metastases","volume":"8","author":"Salmaggi","year":"2009","journal-title":"Cancer Biol. Ther."},{"issue":"5","key":"10.1016\/j.semcancer.2021.12.009_bib0135","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1016\/j.cell.2020.09.064","article-title":"CNS-native myeloid cells drive immune suppression in the brain metastatic niche through Cxcl10","volume":"183","author":"Guldner","year":"2020","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.semcancer.2021.12.009_bib0140","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.stem.2007.06.002","article-title":"Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer","volume":"1","author":"Hermann","year":"2007","journal-title":"Cell Stem Cell"},{"issue":"4","key":"10.1016\/j.semcancer.2021.12.009_bib0145","first-page":"1295","article-title":"Heterogeneity of chemokine cell-surface receptor expression in triple-negative breast cancer","volume":"5","author":"Norton","year":"2015","journal-title":"Am. J. Cancer Res."},{"issue":"1","key":"10.1016\/j.semcancer.2021.12.009_bib0150","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13010142","article-title":"The network of cytokines in brain metastases","volume":"13","author":"Fares","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.semcancer.2021.12.009_bib0155","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1093\/intbio\/zyaa001","article-title":"Lymphoidal chemokine CCL19 promoted the heterogeneity of the breast tumor cell motility within a 3D microenvironment revealed by a Levy distribution analysis","volume":"12","author":"Kim","year":"2020","journal-title":"Integr. Biol. (Camb)"},{"key":"10.1016\/j.semcancer.2021.12.009_bib0160","doi-asserted-by":"crossref","first-page":"952","DOI":"10.3389\/fimmu.2020.00952","article-title":"Beyond cell motility: the expanding roles of chemokines and their receptors in malignancy","volume":"11","author":"Morein","year":"2020","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.semcancer.2021.12.009_bib0165","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s10585-007-9097-3","article-title":"Organ selectivity in metastasis: regulation by chemokines and their receptors","volume":"25","author":"Ben-Baruch","year":"2008","journal-title":"Clin. Exp. Metastasis"},{"issue":"1","key":"10.1016\/j.semcancer.2021.12.009_bib0170","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1097\/01.sla.0000217690.65909.9c","article-title":"Chemokine receptor CXCR4 expression in patients with melanoma and colorectal cancer liver metastases and the association with disease outcome","volume":"244","author":"Kim","year":"2006","journal-title":"Ann. Surg."},{"issue":"2","key":"10.1016\/j.semcancer.2021.12.009_bib0175","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jdermsci.2004.03.002","article-title":"Chemokine receptors and melanoma metastasis","volume":"36","author":"Murakami","year":"2004","journal-title":"J. Dermatol. Sci."},{"issue":"9","key":"10.1016\/j.semcancer.2021.12.009_bib0180","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/nri.2017.49","article-title":"Chemokines in the cancer microenvironment and their relevance in cancer immunotherapy","volume":"17","author":"Nagarsheth","year":"2017","journal-title":"Nat. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.semcancer.2021.12.009_bib0185","first-page":"7","article-title":"Cancer statistics, 2016","volume":"66","author":"Siegel","year":"2016","journal-title":"CA Cancer J. Clin."},{"issue":"4","key":"10.1016\/j.semcancer.2021.12.009_bib0190","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1007\/s40610-017-0073-7","article-title":"Tumor microenvironment heterogeneity: challenges and opportunities","volume":"3","author":"Runa","year":"2017","journal-title":"Curr. Mol. Biol. Rep."},{"issue":"6","key":"10.1016\/j.semcancer.2021.12.009_bib0195","doi-asserted-by":"crossref","first-page":"R187","DOI":"10.1530\/ERC-12-0085","article-title":"The reactive stroma microenvironment and prostate cancer progression","volume":"19","author":"Barron","year":"2012","journal-title":"Endocr. Relat. Cancer"},{"issue":"3","key":"10.1016\/j.semcancer.2021.12.009_bib0200","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.ccr.2012.02.022","article-title":"Accessories to the crime: functions of cells recruited to the tumor microenvironment","volume":"21","author":"Hanahan","year":"2012","journal-title":"Cancer Cell"},{"issue":"9","key":"10.1016\/j.semcancer.2021.12.009_bib0205","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1038\/nrc.2016.73","article-title":"The biology and function of fibroblasts in cancer","volume":"16","author":"Kalluri","year":"2016","journal-title":"Nat. Rev. Cancer"},{"issue":"8","key":"10.1016\/j.semcancer.2021.12.009_bib0210","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/ncb3015","article-title":"The tumour-induced systemic environment as a critical regulator of cancer progression and metastasis","volume":"16","author":"McAllister","year":"2014","journal-title":"Nat. Cell Biol."},{"issue":"1","key":"10.1016\/j.semcancer.2021.12.009_bib0215","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.canlet.2015.12.022","article-title":"Regulation of prostate cancer progression by the tumor microenvironment","volume":"380","author":"Shiao","year":"2016","journal-title":"Cancer Lett."},{"issue":"3","key":"10.1016\/j.semcancer.2021.12.009_bib0220","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.cmet.2019.08.013","article-title":"Mechanisms and implications of metabolic heterogeneity in Cancer","volume":"30","author":"Kim","year":"2019","journal-title":"Cell Metab."},{"issue":"11","key":"10.1016\/j.semcancer.2021.12.009_bib0225","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1038\/nm.3394","article-title":"Microenvironmental regulation of tumor progression and metastasis","volume":"19","author":"Quail","year":"2013","journal-title":"Nat. Med."},{"issue":"3","key":"10.1016\/j.semcancer.2021.12.009_bib0230","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.ccell.2017.02.009","article-title":"The microenvironmental landscape of brain tumors","volume":"31","author":"Quail","year":"2017","journal-title":"Cancer Cell"},{"issue":"Pt 23","key":"10.1016\/j.semcancer.2021.12.009_bib0235","doi-asserted-by":"crossref","first-page":"5591","DOI":"10.1242\/jcs.116392","article-title":"The tumor microenvironment at a glance","volume":"125","author":"Balkwill","year":"2012","journal-title":"J. Cell. Sci."},{"key":"10.1016\/j.semcancer.2021.12.009_bib0240","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.canlet.2019.07.010","article-title":"The tumour microenvironment as an integrated framework to understand cancer biology","volume":"461","author":"Burgos-Panadero","year":"2019","journal-title":"Cancer Lett."},{"issue":"7520","key":"10.1016\/j.semcancer.2021.12.009_bib0245","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1038\/nature13556","article-title":"Non-cell-autonomous driving of tumour growth supports sub-clonal heterogeneity","volume":"514","author":"Marusyk","year":"2014","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.semcancer.2021.12.009_bib0250","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/ni.3666","article-title":"The movers and shapers in immune privilege of the CNS","volume":"18","author":"Engelhardt","year":"2017","journal-title":"Nat. Immunol."},{"issue":"10","key":"10.1016\/j.semcancer.2021.12.009_bib0255","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.it.2015.08.006","article-title":"Revisiting the mechanisms of CNS immune privilege","volume":"36","author":"Louveau","year":"2015","journal-title":"Trends Immunol."},{"issue":"1","key":"10.1016\/j.semcancer.2021.12.009_bib0260","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/cns.13569","article-title":"Peripheral inflammation and blood-brain barrier disruption: effects and mechanisms","volume":"27","author":"Huang","year":"2021","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.semcancer.2021.12.009_bib0265","doi-asserted-by":"crossref","first-page":"521","DOI":"10.3389\/fnins.2019.00521","article-title":"Role of the blood-brain barrier in central nervous system insulin resistance","volume":"13","author":"Rhea","year":"2019","journal-title":"Front. Neurosci."},{"issue":"Pt 1","key":"10.1016\/j.semcancer.2021.12.009_bib0270","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.mod.2015.07.001","article-title":"Vascularisation of the central nervous system","author":"Tata","year":"2015","journal-title":"Mech Dev 138"},{"key":"10.1016\/j.semcancer.2021.12.009_bib0275","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1186\/1742-2094-9-155","article-title":"Neuroimmune crosstalk in the central nervous system and its significance for neurological diseases","volume":"9","author":"Tian","year":"2012","journal-title":"J. Neuroinflammation"},{"issue":"7560","key":"10.1016\/j.semcancer.2021.12.009_bib0280","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nature14432","article-title":"Structural and functional features of central nervous system lymphatic vessels","volume":"523","author":"Louveau","year":"2015","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.semcancer.2021.12.009_bib0285","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1089\/ars.2007.1634","article-title":"Brain tissue oxygen concentration measurements","volume":"9","author":"Ndubuizu","year":"2007","journal-title":"Antioxid. Redox Signal."},{"issue":"1","key":"10.1016\/j.semcancer.2021.12.009_bib0290","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.bbcan.2016.12.001","article-title":"Brain metastasis: unique challenges and open opportunities","volume":"1867","author":"Lowery","year":"2017","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"issue":"3","key":"10.1016\/j.semcancer.2021.12.009_bib0295","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.suronc.2011.09.001","article-title":"The tumor microenvironment","volume":"21","author":"Weber","year":"2012","journal-title":"Surg. Oncol."},{"issue":"1","key":"10.1016\/j.semcancer.2021.12.009_bib0300","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.canlet.2005.12.005","article-title":"The tumor microenvironment in the post-PAGET era","volume":"242","author":"Witz","year":"2006","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/j.semcancer.2021.12.009_bib0305","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.cmet.2019.06.001","article-title":"Macrophages and metabolism in the tumor microenvironment","volume":"30","author":"Vitale","year":"2019","journal-title":"Cell Metab."},{"key":"10.1016\/j.semcancer.2021.12.009_bib0310","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.semcancer.2019.07.028","article-title":"Recruitment of stromal cells into tumour microenvironment promote the metastatic spread of breast cancer","volume":"60","author":"Hill","year":"2020","journal-title":"Semin. Cancer Biol."},{"issue":"12","key":"10.1016\/j.semcancer.2021.12.009_bib0315","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.15252\/embr.201439246","article-title":"The extracellular matrix modulates the hallmarks of cancer","volume":"15","author":"Pickup","year":"2014","journal-title":"EMBO Rep."},{"issue":"14","key":"10.1016\/j.semcancer.2021.12.009_bib0320","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.7150\/ijbs.25720","article-title":"Effect of stromal cells in tumor microenvironment on metastasis initiation","volume":"14","author":"Guo","year":"2018","journal-title":"Int. J. Biol. Sci."},{"issue":"12","key":"10.1016\/j.semcancer.2021.12.009_bib0325","doi-asserted-by":"crossref","first-page":"3011","DOI":"10.1158\/0008-5472.CAN-19-0458","article-title":"Defining the hallmarks of metastasis","volume":"79","author":"Welch","year":"2019","journal-title":"Cancer Res."},{"issue":"10","key":"10.1016\/j.semcancer.2021.12.009_bib0330","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1038\/nrclinonc.2017.44","article-title":"EMT, CSCs, and drug resistance: the mechanistic link and clinical implications","volume":"14","author":"Shibue","year":"2017","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.semcancer.2021.12.009_bib0335","doi-asserted-by":"crossref","DOI":"10.1080\/20013078.2019.1627164","article-title":"Brainwashed by extracellular vesicles: the role of extracellular vesicles in primary and metastatic brain tumour microenvironment","volume":"8","author":"Morad","year":"2019","journal-title":"J. Extracell. Vesicles"},{"issue":"8","key":"10.1016\/j.semcancer.2021.12.009_bib0340","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1038\/s41582-018-0025-8","article-title":"Multidimensional communication in the microenvirons of glioblastoma","volume":"14","author":"Broekman","year":"2018","journal-title":"Nat. Rev. Neurol."},{"issue":"5","key":"10.1016\/j.semcancer.2021.12.009_bib0345","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/nrc3053","article-title":"Brain metastases as preventive and therapeutic targets","volume":"11","author":"Steeg","year":"2011","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"10.1016\/j.semcancer.2021.12.009_bib0350","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s10571-004-1374-y","article-title":"Dynamics of CNS barriers: evolution, differentiation, and modulation","volume":"25","author":"Abbott","year":"2005","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.semcancer.2021.12.009_bib0355","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/261750","article-title":"Tumor angiogenesis: pericytes and maturation are not to be ignored","volume":"2012","author":"Fakhrejahani","year":"2012","journal-title":"J. Oncol."},{"key":"10.1016\/j.semcancer.2021.12.009_bib0360","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1478-811X-6-10","article-title":"Extravasation of leukocytes in comparison to tumor cells","volume":"6","author":"Strell","year":"2008","journal-title":"Cell Commun. Signal"},{"issue":"7249","key":"10.1016\/j.semcancer.2021.12.009_bib0365","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1038\/nature08021","article-title":"Genes that mediate breast cancer metastasis to the brain","volume":"459","author":"Bos","year":"2009","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.semcancer.2021.12.009_bib0370","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1038\/bjc.2013.242","article-title":"TNF-receptor-1 adaptor protein FAN mediates TNF-induced B16 melanoma motility and invasion","volume":"109","author":"Boecke","year":"2013","journal-title":"Br. J. Cancer"},{"issue":"31","key":"10.1016\/j.semcancer.2021.12.009_bib0375","doi-asserted-by":"crossref","first-page":"4449","DOI":"10.1038\/onc.2010.185","article-title":"Regulation of invasive behavior by vascular endothelial growth factor is HEF1-dependent","volume":"29","author":"Lucas","year":"2010","journal-title":"Oncogene"},{"issue":"3","key":"10.1016\/j.semcancer.2021.12.009_bib0380","doi-asserted-by":"crossref","first-page":"179","DOI":"10.2174\/157015908785777210","article-title":"Brain endothelial cell-cell junctions: how to \u201copen\u201d the blood brain barrier","volume":"6","author":"Stamatovic","year":"2008","journal-title":"Curr. Neuropharmacol."},{"issue":"21","key":"10.1016\/j.semcancer.2021.12.009_bib0385","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1101\/gad.250647.114","article-title":"Pericellular proteolysis in cancer","volume":"28","author":"Sevenich","year":"2014","journal-title":"Genes Dev."},{"issue":"2","key":"10.1016\/j.semcancer.2021.12.009_bib0390","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/jcbfm.2012.165","article-title":"Oxygen consumption rates during three different neuronal activity states in the hippocampal CA3 network","volume":"33","author":"Huchzermeyer","year":"2013","journal-title":"J. Cereb. Blood Flow Metab."},{"issue":"1","key":"10.1016\/j.semcancer.2021.12.009_bib0395","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/nm.2072","article-title":"Real-time imaging reveals the single steps of brain metastasis formation","volume":"16","author":"Kienast","year":"2010","journal-title":"Nat. Med."},{"issue":"5","key":"10.1016\/j.semcancer.2021.12.009_bib0400","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/j.cell.2014.01.040","article-title":"Serpins promote cancer cell survival and vascular co-option in brain metastasis","volume":"156","author":"Valiente","year":"2014","journal-title":"Cell"},{"issue":"5422","key":"10.1016\/j.semcancer.2021.12.009_bib0405","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1126\/science.284.5422.1994","article-title":"Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF","volume":"284","author":"Holash","year":"1999","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.semcancer.2021.12.009_bib0410","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.cell.2009.04.030","article-title":"WNT\/TCF signaling through LEF1 and HOXB9 mediates lung adenocarcinoma metastasis","volume":"138","author":"Nguyen","year":"2009","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.semcancer.2021.12.009_bib0415","doi-asserted-by":"crossref","first-page":"2958","DOI":"10.2353\/ajpath.2010.090838","article-title":"Capturing changes in the brain microenvironment during initial steps of breast cancer brain metastasis","volume":"176","author":"Lorger","year":"2010","journal-title":"Am. J. Pathol."},{"issue":"12","key":"10.1016\/j.semcancer.2021.12.009_bib0420","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1093\/neuonc\/not112","article-title":"Invasion patterns in brain metastases of solid cancers","volume":"15","author":"Berghoff","year":"2013","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.semcancer.2021.12.009_bib0425","doi-asserted-by":"crossref","DOI":"10.1038\/srep23834","article-title":"Imaging of Angiotropism\/Vascular Co-option in a murine model of brain melanoma: implications for melanoma progression along extravascular pathways","volume":"6","author":"Bentolila","year":"2016","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.semcancer.2021.12.009_bib0430","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0005857","article-title":"The vascular basement membrane as \"soil\" in brain metastasis","volume":"4","author":"Carbonell","year":"2009","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.semcancer.2021.12.009_bib0435","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.3171\/2016.4.JNS152319","article-title":"Discovery of additional brain metastases on the day of stereotactic radiosurgery: risk factors and outcomes","volume":"126","author":"Garcia","year":"2017","journal-title":"J. Neurosurg."},{"issue":"7604","key":"10.1016\/j.semcancer.2021.12.009_bib0440","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/nature18268","article-title":"Carcinoma-astrocyte gap junctions promote brain metastasis by cGAMP transfer","volume":"533","author":"Chen","year":"2016","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.semcancer.2021.12.009_bib0445","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1002\/emmm.201201623","article-title":"Reactive astrocytes promote the metastatic growth of breast cancer stem-like cells by activating Notch signalling in brain","volume":"5","author":"Xing","year":"2013","journal-title":"EMBO Mol. Med."},{"issue":"9","key":"10.1016\/j.semcancer.2021.12.009_bib0450","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1593\/neo.10602","article-title":"Reactive astrocytes protect melanoma cells from chemotherapy by sequestering intracellular calcium through gap junction communication channels","volume":"12","author":"Lin","year":"2010","journal-title":"Neoplasia"},{"issue":"Pt 4","key":"10.1016\/j.semcancer.2021.12.009_bib0455","first-page":"904","article-title":"Role of connexins in metastatic breast cancer and melanoma brain colonization","volume":"126","author":"Stoletov","year":"2013","journal-title":"J. Cell. Sci."},{"issue":"3","key":"10.1016\/j.semcancer.2021.12.009_bib0460","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1593\/neo.11112","article-title":"Astrocytes upregulate survival genes in tumor cells and induce protection from chemotherapy","volume":"13","author":"Kim","year":"2011","journal-title":"Neoplasia"},{"issue":"4","key":"10.1016\/j.semcancer.2021.12.009_bib0465","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s10585-016-9784-z","article-title":"Characterization of passive permeability at the blood-tumor barrier in five preclinical models of brain metastases of breast cancer","volume":"33","author":"Adkins","year":"2016","journal-title":"Clin. Exp. Metastasis"},{"issue":"23","key":"10.1016\/j.semcancer.2021.12.009_bib0470","doi-asserted-by":"crossref","first-page":"5664","DOI":"10.1158\/1078-0432.CCR-10-1564","article-title":"Heterogeneous blood-tumor barrier permeability determines drug efficacy in experimental brain metastases of breast cancer","volume":"16","author":"Lockman","year":"2010","journal-title":"Clin. Cancer Res."},{"issue":"7576","key":"10.1016\/j.semcancer.2021.12.009_bib0475","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/nature15376","article-title":"Microenvironment-induced PTEN loss by exosomal microRNA primes brain metastasis outgrowth","volume":"527","author":"Zhang","year":"2015","journal-title":"Nature"},{"issue":"473","key":"10.1016\/j.semcancer.2021.12.009_bib0480","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.aai7696","article-title":"Astrocyte-shed extracellular vesicles regulate the peripheral leukocyte response to inflammatory brain lesions","volume":"10","author":"Dickens","year":"2017","journal-title":"Sci. Signal."},{"issue":"15","key":"10.1016\/j.semcancer.2021.12.009_bib0485","doi-asserted-by":"crossref","first-page":"4359","DOI":"10.1158\/0008-5472.CAN-16-0485","article-title":"Incipient melanoma brain metastases instigate astrogliosis and neuroinflammation","volume":"76","author":"Schwartz","year":"2016","journal-title":"Cancer Res."},{"issue":"7","key":"10.1016\/j.semcancer.2021.12.009_bib0490","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1016\/j.celrep.2019.07.033","article-title":"Inflammatory activation of astrocytes facilitates melanoma brain tropism via the CXCL10-CXCR3 signaling axis","volume":"28","author":"Doron","year":"2019","journal-title":"Cell Rep."},{"issue":"9","key":"10.1016\/j.semcancer.2021.12.009_bib0495","doi-asserted-by":"crossref","first-page":"590","DOI":"10.52586\/4969","article-title":"The role of astrocytes in brain metastasis at the interface of circulating tumour cells and the blood brain barrier","volume":"26","author":"Burn","year":"2021","journal-title":"Front. Biosci. (Landmark Ed)"},{"key":"10.1016\/j.semcancer.2021.12.009_bib0500","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/978-3-030-73119-9_4","article-title":"Studying the tumor microenvironment in zebrafish","volume":"1329","author":"Sturtzel","year":"2021","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.semcancer.2021.12.009_bib0505","article-title":"CXCL8 is a prognostic biomarker and correlated with TNBC brain metastasis and immune infiltration","volume":"103","author":"Shen","year":"2021","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.semcancer.2021.12.009_bib0510","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.780744","article-title":"circRNAs: insight into their role in tumor-associated macrophages","volume":"11","author":"Duan","year":"2021","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.semcancer.2021.12.009_bib0515","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12967-019-02189-8","article-title":"Tumor microenvironment differences between primary tumor and brain metastases","volume":"18","author":"Cacho-Diaz","year":"2020","journal-title":"J. Transl. Med."},{"issue":"8","key":"10.1016\/j.semcancer.2021.12.009_bib0520","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20191131","article-title":"Nicotine promotes brain metastasis by polarizing microglia and suppressing innate immune function","volume":"217","author":"Wu","year":"2020","journal-title":"J. Exp. Med."},{"issue":"11","key":"10.1016\/j.semcancer.2021.12.009_bib0525","doi-asserted-by":"crossref","first-page":"2438","DOI":"10.1002\/glia.23485","article-title":"PI3K: A master regulator of brain metastasis-promoting macrophages\/microglia","volume":"66","author":"Blazquez","year":"2018","journal-title":"Glia"},{"issue":"8","key":"10.1016\/j.semcancer.2021.12.009_bib0530","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1002\/glia.22518","article-title":"Carcinoma cells misuse the host tissue damage response to invade the brain","volume":"61","author":"Chuang","year":"2013","journal-title":"Glia"},{"issue":"14","key":"10.1016\/j.semcancer.2021.12.009_bib0535","doi-asserted-by":"crossref","first-page":"6231","DOI":"10.7150\/thno.45219","article-title":"Emerging role of mTOR in tumor immune contexture: impact on chemokine-related immune cells migration","volume":"10","author":"Jin","year":"2020","journal-title":"Theranostics"},{"issue":"6","key":"10.1016\/j.semcancer.2021.12.009_bib0540","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/j.ccell.2019.05.004","article-title":"Cooperation between constitutive and inducible chemokines enables t cell engraftment and immune attack in solid tumors","volume":"35","author":"Dangaj","year":"2019","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.semcancer.2021.12.009_bib0545","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.immuni.2018.06.006","article-title":"Tumor cell-intrinsic factors underlie heterogeneity of immune cell infiltration and response to immunotherapy","volume":"49","author":"Li","year":"2018","journal-title":"Immunity"},{"key":"10.1016\/j.semcancer.2021.12.009_bib0550","doi-asserted-by":"crossref","first-page":"7458","DOI":"10.1038\/ncomms8458","article-title":"Non-redundant requirement for CXCR3 signalling during tumoricidal T-cell trafficking across tumour vascular checkpoints","volume":"6","author":"Mikucki","year":"2015","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.semcancer.2021.12.009_bib0555","first-page":"33","article-title":"The role of the immune system in brain metastasis","volume":"10","author":"Leibold","year":"2019","journal-title":"Curr. Neurobiol."},{"issue":"Pt B","key":"10.1016\/j.semcancer.2021.12.009_bib0560","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.addr.2015.07.007","article-title":"Phenotypic and functional heterogeneity of cancer-associated fibroblast within the tumor microenvironment","volume":"99","author":"Ishii","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.semcancer.2021.12.009_bib0565","doi-asserted-by":"crossref","first-page":"2674","DOI":"10.2741\/2874","article-title":"The role of chemokines in leucocyte-stromal interactions in rheumatoid arthritis","volume":"13","author":"Filer","year":"2008","journal-title":"Front Biosci"},{"key":"10.1016\/j.semcancer.2021.12.009_bib0570","doi-asserted-by":"crossref","first-page":"901","DOI":"10.3389\/fimmu.2020.00901","article-title":"Role of CC chemokines subfamily in the platinum drugs resistance promotion in Cancer","volume":"11","author":"Reyes","year":"2020","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.semcancer.2021.12.009_bib0575","doi-asserted-by":"crossref","DOI":"10.1242\/dmm.029447","article-title":"A peek into cancer-associated fibroblasts: origins, functions and translational impact","volume":"11","author":"LeBleu","year":"2018","journal-title":"Dis. Model. Mech."},{"key":"10.1016\/j.semcancer.2021.12.009_bib0580","doi-asserted-by":"crossref","first-page":"563","DOI":"10.3389\/fimmu.2018.00563","article-title":"Immunological approaches towards Cancer and inflammation: a cross talk","volume":"9","author":"Qu","year":"2018","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.semcancer.2021.12.009_bib0585","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1189\/jlb.0310182","article-title":"Chemokines at the crossroads of tumor-fibroblast interactions that promote malignancy","volume":"89","author":"Mishra","year":"2011","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.semcancer.2021.12.009_bib0590","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/s41523-017-0008-8","article-title":"Human brain metastatic stroma attracts breast cancer cells via chemokines CXCL16 and CXCL12","volume":"3","author":"Chung","year":"2017","journal-title":"NPJ Breast Cancer"},{"issue":"1","key":"10.1016\/j.semcancer.2021.12.009_bib0595","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.canlet.2016.05.022","article-title":"Cancer-associated fibroblasts promote hepatocellular carcinoma metastasis through chemokine-activated hedgehog and TGF-beta pathways","volume":"379","author":"Liu","year":"2016","journal-title":"Cancer Lett."},{"issue":"32","key":"10.1016\/j.semcancer.2021.12.009_bib0600","doi-asserted-by":"crossref","first-page":"4428","DOI":"10.1038\/s41388-018-0263-7","article-title":"Fibroblast-derived CXCL12 promotes breast cancer metastasis by facilitating tumor cell intravasation","volume":"37","author":"Ahirwar","year":"2018","journal-title":"Oncogene"},{"issue":"2","key":"10.1016\/j.semcancer.2021.12.009_bib0605","doi-asserted-by":"crossref","first-page":"129","DOI":"10.20892\/j.issn.2095-3941.2016.0033","article-title":"Mesenchymal stromal cells\u2019 role in tumor microenvironment: involvement of signaling pathways","volume":"14","author":"Nwabo Kamdje","year":"2017","journal-title":"Cancer Biol. Med."},{"key":"10.1016\/j.semcancer.2021.12.009_bib0610","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.3389\/fimmu.2018.01342","article-title":"Corrigendum: How to Hit Mesenchymal Stromal Cells and Make the Tumor Microenvironment Immunostimulant Rather Than Immunosuppressive","volume":"9","author":"Poggi","year":"2018","journal-title":"Front. Immunol."},{"issue":"27","key":"10.1016\/j.semcancer.2021.12.009_bib0615","doi-asserted-by":"crossref","first-page":"43897","DOI":"10.18632\/oncotarget.14915","article-title":"miRNA-1246 induces pro-inflammatory responses in mesenchymal stem\/stromal cells by regulating PKA and PP2A","volume":"8","author":"Bott","year":"2017","journal-title":"Oncotarget"},{"issue":"12","key":"10.1016\/j.semcancer.2021.12.009_bib0620","doi-asserted-by":"crossref","first-page":"19592","DOI":"10.18632\/oncotarget.14752","article-title":"Cancer-associated fibroblasts release exosomal microRNAs that dictate an aggressive phenotype in breast cancer","volume":"8","author":"Donnarumma","year":"2017","journal-title":"Oncotarget"},{"issue":"5","key":"10.1016\/j.semcancer.2021.12.009_bib0625","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/j.celrep.2016.12.079","article-title":"Mesenchymal stem cell-induced DDR2 mediates stromal-breast Cancer interactions and metastasis growth","volume":"18","author":"Gonzalez","year":"2017","journal-title":"Cell Rep."},{"issue":"5","key":"10.1016\/j.semcancer.2021.12.009_bib0630","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1038\/onc.2009.308","article-title":"The role of proto-oncogene Fra-1 in remodeling the tumor microenvironment in support of breast tumor cell invasion and progression","volume":"29","author":"Luo","year":"2010","journal-title":"Oncogene"},{"key":"10.1016\/j.semcancer.2021.12.009_bib0635","doi-asserted-by":"crossref","first-page":"16941","DOI":"10.1038\/srep16941","article-title":"Mesenchymal stem cells induce directional migration of invasive breast Cancer cells through TGF-beta","volume":"5","author":"McAndrews","year":"2015","journal-title":"Sci. Rep."},{"issue":"50","key":"10.1016\/j.semcancer.2021.12.009_bib0640","doi-asserted-by":"crossref","first-page":"82482","DOI":"10.18632\/oncotarget.12694","article-title":"Mesenchymal stem cells and macrophages interact through IL-6 to promote inflammatory breast cancer in pre-clinical models","volume":"7","author":"Wolfe","year":"2016","journal-title":"Oncotarget"},{"issue":"4","key":"10.1016\/j.semcancer.2021.12.009_bib0645","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1038\/onc.2016.217","article-title":"TNFalpha-activated mesenchymal stromal cells promote breast cancer metastasis by recruiting CXCR2(+) neutrophils","volume":"36","author":"Yu","year":"2017","journal-title":"Oncogene"},{"key":"10.1016\/j.semcancer.2021.12.009_bib0650","article-title":"Mesenchymal stromal cell-derived extracellular vesicles in the treatment of diabetic foot ulcers: application and challenges","author":"An","year":"2020","journal-title":"Stem. Cell Rev. Rep."},{"issue":"6","key":"10.1016\/j.semcancer.2021.12.009_bib0655","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1016\/j.yjmcc.2008.03.010","article-title":"Characterization of key mechanisms in transmigration and invasion of mesenchymal stem cells","volume":"44","author":"Steingen","year":"2008","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"3","key":"10.1016\/j.semcancer.2021.12.009_bib0660","doi-asserted-by":"crossref","first-page":"703","DOI":"10.7150\/jca.50277","article-title":"Decoding Immune Heterogeneity of Melanoma and identifying immune-prognostic hub genes","volume":"12","author":"Zhang","year":"2021","journal-title":"J. Cancer"},{"issue":"9","key":"10.1016\/j.semcancer.2021.12.009_bib0665","doi-asserted-by":"crossref","first-page":"5498","DOI":"10.4049\/jimmunol.0801284","article-title":"Oncoprotein signaling mediates tumor-specific inflammation and enhances tumor progression","volume":"182","author":"Pufnock","year":"2009","journal-title":"J. Immunol."},{"issue":"8","key":"10.1016\/j.semcancer.2021.12.009_bib0670","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11081205","article-title":"The complex interaction between the tumor micro-environment and immune checkpoints in breast Cancer","volume":"11","author":"Barriga","year":"2019","journal-title":"Cancers (Basel)"},{"issue":"3","key":"10.1016\/j.semcancer.2021.12.009_bib0675","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.ccr.2005.02.013","article-title":"Smoldering and polarized inflammation in the initiation and promotion of malignant disease","volume":"7","author":"Balkwill","year":"2005","journal-title":"Cancer Cell"},{"issue":"10","key":"10.1016\/j.semcancer.2021.12.009_bib0680","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1038\/ni.2703","article-title":"Innate and adaptive immune cells in the tumor microenvironment","volume":"14","author":"Gajewski","year":"2013","journal-title":"Nat. Immunol."},{"issue":"19","key":"10.1016\/j.semcancer.2021.12.009_bib0685","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1038\/onc.2013.191","article-title":"Cancer-associated fibroblasts and M2-polarized macrophages synergize during prostate carcinoma progression","volume":"33","author":"Comito","year":"2014","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.semcancer.2021.12.009_bib0690","doi-asserted-by":"crossref","first-page":"3172","DOI":"10.1038\/s41598-019-39553-z","article-title":"Cancer associated fibroblasts sculpt tumour microenvironment by recruiting monocytes and inducing immunosuppressive PD-1(+) TAMs","volume":"9","author":"Gok Yavuz","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.semcancer.2021.12.009_bib0695","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s12943-015-0488-9","article-title":"Estrogen receptor alpha in cancer associated fibroblasts suppresses prostate cancer invasion via reducing CCL5, IL6 and macrophage infiltration in the tumor microenvironment","volume":"15","author":"Yeh","year":"2016","journal-title":"Mol. Cancer"},{"issue":"7203","key":"10.1016\/j.semcancer.2021.12.009_bib0700","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/nature07205","article-title":"Cancer-related inflammation","volume":"454","author":"Mantovani","year":"2008","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.semcancer.2021.12.009_bib0705","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s00109-013-1021-5","article-title":"The metastasis-promoting roles of tumor-associated immune cells","volume":"91","author":"Smith","year":"2013","journal-title":"J. Mol. Med."},{"key":"10.1016\/j.semcancer.2021.12.009_bib0710","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1146\/annurev.immunol.25.022106.141609","article-title":"Immunosuppressive strategies that are mediated by tumor cells","volume":"25","author":"Rabinovich","year":"2007","journal-title":"Annu. Rev. Immunol."},{"issue":"5","key":"10.1016\/j.semcancer.2021.12.009_bib0715","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/j.immuni.2014.09.014","article-title":"Molecular profiling reveals a tumor-promoting phenotype of monocytes and macrophages in human cancer progression","volume":"41","author":"Chittezhath","year":"2014","journal-title":"Immunity"},{"key":"10.1016\/j.semcancer.2021.12.009_bib0720","doi-asserted-by":"crossref","first-page":"398","DOI":"10.3389\/fimmu.2018.00398","article-title":"Targeting myeloid-derived suppressor cells to bypass tumor-induced immunosuppression","volume":"9","author":"Fleming","year":"2018","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.semcancer.2021.12.009_bib0725","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a016303","article-title":"The chemokine system in innate immunity","volume":"7","author":"Sokol","year":"2015","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.semcancer.2021.12.009_bib0730","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/480739","article-title":"Cytokines and chemokines at the crossroads of neuroinflammation, neurodegeneration, and neuropathic pain","volume":"2013","author":"Ramesh","year":"2013","journal-title":"Mediators Inflamm."},{"issue":"2","key":"10.1016\/j.semcancer.2021.12.009_bib0735","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.canlet.2007.05.013","article-title":"Role of chemokines in tumor growth","volume":"256","author":"Raman","year":"2007","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/j.semcancer.2021.12.009_bib0740","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s12943-019-0973-7","article-title":"Microvesicles and chemokines in tumor microenvironment: mediators of intercellular communications in tumor progression","volume":"18","author":"Bian","year":"2019","journal-title":"Mol. Cancer"},{"issue":"3","key":"10.1016\/j.semcancer.2021.12.009_bib0745","doi-asserted-by":"crossref","first-page":"C542","DOI":"10.1152\/ajpcell.00378.2019","article-title":"The CC and CXC chemokines: major regulators of tumor progression and the tumor microenvironment","volume":"318","author":"Bikfalvi","year":"2020","journal-title":"Am. J. Physiol., Cell Physiol."},{"issue":"7","key":"10.1016\/j.semcancer.2021.12.009_bib0750","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1038\/nrc1388","article-title":"Cancer and the chemokine network","volume":"4","author":"Balkwill","year":"2004","journal-title":"Nat. Rev. Cancer"},{"issue":"2","key":"10.1016\/j.semcancer.2021.12.009_bib0755","first-page":"100","article-title":"Brain metastases from colorectal cancer: risk factors, incidence, and the possible role of chemokines","volume":"8","author":"Mongan","year":"2009","journal-title":"Clin. Colorectal Cancer"},{"issue":"7","key":"10.1016\/j.semcancer.2021.12.009_bib0760","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1038\/onc.2015.139","article-title":"CXCL12\/CXCR4: a symbiotic bridge linking cancer cells and their stromal neighbors in oncogenic communication networks","volume":"35","author":"Guo","year":"2016","journal-title":"Oncogene"},{"key":"10.1016\/j.semcancer.2021.12.009_bib0765","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.117534","article-title":"CXCL12\/CXCR4 axis in the microenvironment of solid tumors: a critical mediator of metastasis","volume":"249","author":"Mortezaee","year":"2020","journal-title":"Life Sci."},{"issue":"5","key":"10.1016\/j.semcancer.2021.12.009_bib0770","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.ccell.2016.09.011","article-title":"Characteristics and significance of the pre-metastatic niche","volume":"30","author":"Liu","year":"2016","journal-title":"Cancer Cell"},{"issue":"21","key":"10.1016\/j.semcancer.2021.12.009_bib0775","doi-asserted-by":"crossref","first-page":"3898","DOI":"10.7150\/jca.26383","article-title":"The role of CXCL12 Axis in lung metastasis of colorectal Cancer","volume":"9","author":"Wang","year":"2018","journal-title":"J. Cancer"},{"issue":"1","key":"10.1016\/j.semcancer.2021.12.009_bib0780","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.3390\/ijms14011713","article-title":"CXCR4\/CXCL12 in non-small-cell lung cancer metastasis to the brain","volume":"14","author":"Cavallaro","year":"2013","journal-title":"Int. J. Mol. Sci."},{"issue":"12","key":"10.1016\/j.semcancer.2021.12.009_bib0785","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1016\/j.bcp.2007.08.025","article-title":"Stromal cell-derived factor-1 enhances motility and integrin up-regulation through CXCR4, ERK and NF-kappaB-dependent pathway in human lung cancer cells","volume":"74","author":"Huang","year":"2007","journal-title":"Biochem. Pharmacol."},{"issue":"3","key":"10.1016\/j.semcancer.2021.12.009_bib0790","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1002\/jcb.10522","article-title":"Expression of CXCR4 and CXCL12 (SDF-1) in human prostate cancers (PCa) in vivo","volume":"89","author":"Sun","year":"2003","journal-title":"J. Cell. Biochem."},{"issue":"2","key":"10.1016\/j.semcancer.2021.12.009_bib0795","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s10585-008-9210-2","article-title":"Role of the CXCR4\/CXCL12 signaling axis in breast cancer metastasis to the brain","volume":"27","author":"Hinton","year":"2010","journal-title":"Clin. Exp. Metastasis"},{"issue":"5","key":"10.1016\/j.semcancer.2021.12.009_bib0800","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1158\/1078-0432.CCR-04-1887","article-title":"Expression of CXCR4 predicts poor prognosis in patients with malignant melanoma","volume":"11","author":"Scala","year":"2005","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.semcancer.2021.12.009_bib0805","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.105092","article-title":"Relevance of the CXCR4\/CXCR7-CXCL12 axis and its effect in pathophysiological conditions","volume":"161","author":"Huynh","year":"2020","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.semcancer.2021.12.009_bib0810","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.cyto.2017.12.022","article-title":"Multisystem multitasking by CXCL12 and its receptors CXCR4 and ACKR3","volume":"109","author":"Murphy","year":"2018","journal-title":"Cytokine"},{"issue":"2","key":"10.1016\/j.semcancer.2021.12.009_bib0815","doi-asserted-by":"crossref","DOI":"10.3390\/ph13020033","article-title":"Advances in CXCR7 modulators","volume":"13","author":"Lounsbury","year":"2020","journal-title":"Pharmaceuticals (Basel)"},{"issue":"1","key":"10.1016\/j.semcancer.2021.12.009_bib0820","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.cytogfr.2012.08.007","article-title":"Chemokine receptor trio: CXCR3, CXCR4 and CXCR7 crosstalk via CXCL11 and CXCL12","volume":"24","author":"Singh","year":"2013","journal-title":"Cytokine Growth Factor Rev."},{"issue":"7","key":"10.1016\/j.semcancer.2021.12.009_bib0825","doi-asserted-by":"crossref","first-page":"4283","DOI":"10.1074\/jbc.M707465200","article-title":"The role of CXCR7\/RDC1 as a chemokine receptor for CXCL12\/SDF-1 in prostate cancer","volume":"283","author":"Wang","year":"2008","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.semcancer.2021.12.009_bib0830","doi-asserted-by":"crossref","first-page":"R54","DOI":"10.1186\/bcr3665","article-title":"C-X-C motif chemokine 12\/C-X-C chemokine receptor type 7 signaling regulates breast cancer growth and metastasis by modulating the tumor microenvironment","volume":"16","author":"Wani","year":"2014","journal-title":"Breast Cancer Res."},{"issue":"19","key":"10.1016\/j.semcancer.2021.12.009_bib0835","doi-asserted-by":"crossref","first-page":"28697","DOI":"10.18632\/oncotarget.7376","article-title":"Targeting the CCL2-CCR2 signaling axis in cancer metastasis","volume":"7","author":"Lim","year":"2016","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.semcancer.2021.12.009_bib0840","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.neo.2015.11.013","article-title":"Targeting of CCL2-CCR2-Glycosaminoglycan Axis Using a CCL2 decoy protein attenuates metastasis through inhibition of tumor cell seeding","volume":"18","author":"Roblek","year":"2016","journal-title":"Neoplasia"},{"issue":"1","key":"10.1016\/j.semcancer.2021.12.009_bib0845","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s12964-020-00589-8","article-title":"CCL2\/CCR2 signaling in cancer pathogenesis","volume":"18","author":"Hao","year":"2020","journal-title":"Cell Commun. Signal"},{"issue":"3","key":"10.1016\/j.semcancer.2021.12.009_bib0850","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1007\/s10555-020-09881-y","article-title":"Molecular and cellular mechanisms underlying brain metastasis of breast cancer","volume":"39","author":"Hosonaga","year":"2020","journal-title":"Cancer Metastasis Rev."},{"issue":"26","key":"10.1016\/j.semcancer.2021.12.009_bib0855","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abg8139","article-title":"The CCL2-CCR2 astrocyte-cancer cell axis in tumor extravasation at the brain","volume":"7","author":"Hajal","year":"2021","journal-title":"Sci. Adv."},{"key":"10.1016\/j.semcancer.2021.12.009_bib0860","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s13058-015-0573-4","article-title":"Anti-CCL2: building a reservoir or opening the floodgates to metastasis?","volume":"17","author":"Hitchcock","year":"2015","journal-title":"Breast Cancer Res."},{"issue":"6","key":"10.1016\/j.semcancer.2021.12.009_bib0865","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/j.1349-7006.2005.00059.x","article-title":"Chemokines in tumor progression and metastasis","volume":"96","author":"Tanaka","year":"2005","journal-title":"Cancer Sci."},{"issue":"4","key":"10.1016\/j.semcancer.2021.12.009_bib0870","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12041036","article-title":"The role of CCL21\/CCR7 chemokine Axis in breast Cancer progression","volume":"12","author":"Rizeq","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"4","key":"10.1016\/j.semcancer.2021.12.009_bib0875","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.4049\/jimmunol.177.4.2314","article-title":"Opposite fate of endocytosed CCR7 and its ligands: recycling versus degradation","volume":"177","author":"Otero","year":"2006","journal-title":"J. Immunol."},{"issue":"6824","key":"10.1016\/j.semcancer.2021.12.009_bib0880","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/35065016","article-title":"Involvement of chemokine receptors in breast cancer metastasis","volume":"410","author":"Muller","year":"2001","journal-title":"Nature"},{"issue":"16","key":"10.1016\/j.semcancer.2021.12.009_bib0885","doi-asserted-by":"crossref","first-page":"5686","DOI":"10.1158\/1078-0432.CCR-05-0014","article-title":"CCR7 and CXCR4 as novel biomarkers predicting axillary lymph node metastasis in T1 breast cancer","volume":"11","author":"Cabioglu","year":"2005","journal-title":"Clin. Cancer Res."},{"issue":"5","key":"10.1016\/j.semcancer.2021.12.009_bib0890","doi-asserted-by":"crossref","first-page":"R144","DOI":"10.1186\/bcr627","article-title":"Expression pattern of CXC chemokine receptor-4 is correlated with lymph node metastasis in human invasive ductal carcinoma","volume":"5","author":"Kato","year":"2003","journal-title":"Breast Cancer Res."},{"issue":"10","key":"10.1016\/j.semcancer.2021.12.009_bib0895","first-page":"2937","article-title":"Expression of chemokine receptor CCR7 is associated with lymph node metastasis of gastric carcinoma","volume":"62","author":"Mashino","year":"2002","journal-title":"Cancer Res."},{"issue":"5","key":"10.1016\/j.semcancer.2021.12.009_bib0900","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1038\/cdd.2008.190","article-title":"Chemokine receptors CXCR4 and CCR7 promote metastasis by preventing anoikis in cancer cells","volume":"16","author":"Kochetkova","year":"2009","journal-title":"Cell Death Differ."},{"issue":"7249","key":"10.1016\/j.semcancer.2021.12.009_bib0905","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1038\/nature08020","article-title":"CCR7 signalling as an essential regulator of CNS infiltration in T-cell leukaemia","volume":"459","author":"Buonamici","year":"2009","journal-title":"Nature"},{"issue":"5694","key":"10.1016\/j.semcancer.2021.12.009_bib0910","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1126\/science.1102160","article-title":"Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia","volume":"306","author":"Weng","year":"2004","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.semcancer.2021.12.009_bib0915","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/nri2297","article-title":"CCR7 and its ligands: balancing immunity and tolerance","volume":"8","author":"Forster","year":"2008","journal-title":"Nat. Rev. Immunol."},{"issue":"6","key":"10.1016\/j.semcancer.2021.12.009_bib0920","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.ccr.2007.04.020","article-title":"Autologous chemotaxis as a mechanism of tumor cell homing to lymphatics via interstitial flow and autocrine CCR7 signaling","volume":"11","author":"Shields","year":"2007","journal-title":"Cancer Cell"},{"issue":"24","key":"10.1016\/j.semcancer.2021.12.009_bib0925","doi-asserted-by":"crossref","first-page":"11802","DOI":"10.1158\/0008-5472.CAN-06-1222","article-title":"Endothelins induce CCR7 expression by breast tumor cells via endothelin receptor A and hypoxia-inducible factor-1","volume":"66","author":"Wilson","year":"2006","journal-title":"Cancer Res."},{"issue":"5","key":"10.1016\/j.semcancer.2021.12.009_bib0930","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1158\/0008-5472.CAN-04-3531","article-title":"Epigenetic up-regulation of C-C chemokine receptor 7 and C-X-C chemokine receptor 4 expression in melanoma cells","volume":"65","author":"Mori","year":"2005","journal-title":"Cancer Res."},{"issue":"16","key":"10.1016\/j.semcancer.2021.12.009_bib0935","first-page":"4801","article-title":"Down-regulation of CXCR4 by inducible small interfering RNA inhibits breast cancer cell invasion in vitro","volume":"63","author":"Chen","year":"2003","journal-title":"Cancer Res."},{"issue":"3","key":"10.1016\/j.semcancer.2021.12.009_bib0940","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1093\/carcin\/bgq265","article-title":"CC chemokine ligand 21 enhances the immunogenicity of the breast cancer cell line MCF-7 upon assistance of TLR2","volume":"32","author":"Wu","year":"2011","journal-title":"Carcinogenesis"},{"issue":"1","key":"10.1016\/j.semcancer.2021.12.009_bib0945","doi-asserted-by":"crossref","first-page":"8536","DOI":"10.1038\/s41598-017-09113-4","article-title":"Regulation of CCR7-dependent cell migration through CCR7 homodimer formation","volume":"7","author":"Kobayashi","year":"2017","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.semcancer.2021.12.009_bib0950","first-page":"205","article-title":"Targeting PI3K-AKT pathway for cancer therapy","volume":"7","author":"Lu","year":"2003","journal-title":"Rev. Clin. Exp. Hematol."},{"key":"10.1016\/j.semcancer.2021.12.009_bib0955","first-page":"9","article-title":"Implications of chemokine receptors and inflammatory lipids in cancer","volume":"3","author":"Rolin","year":"2014","journal-title":"Immunotargets Ther."},{"key":"10.1016\/j.semcancer.2021.12.009_bib0960","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1034\/j.1600-065X.2000.17712.x","article-title":"Phosphoinositide 3-kinase: a key biochemical signal for cell migration in response to chemokines","volume":"177","author":"Sotsios","year":"2000","journal-title":"Immunol. Rev."},{"issue":"2","key":"10.1016\/j.semcancer.2021.12.009_bib0965","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.joms.2018.09.035","article-title":"CCR4 expression is associated with poor prognosis in patients with early stage (pN0) oral tongue Cancer","volume":"77","author":"Wang","year":"2019","journal-title":"J. Oral Maxillofac. Surg."},{"issue":"2","key":"10.1016\/j.semcancer.2021.12.009_bib0970","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1111\/his.13960","article-title":"C-C chemokine receptor 4 expression in CD8+ cutaneous T-cell lymphomas and lymphoproliferative disorders, and its implications for diagnosis and treatment","volume":"76","author":"Geller","year":"2020","journal-title":"Histopathology"},{"issue":"19","key":"10.1016\/j.semcancer.2021.12.009_bib0975","doi-asserted-by":"crossref","first-page":"31079","DOI":"10.18632\/oncotarget.16076","article-title":"CCR4 is a determinant of melanoma brain metastasis","volume":"8","author":"Klein","year":"2017","journal-title":"Oncotarget"},{"issue":"11","key":"10.1016\/j.semcancer.2021.12.009_bib0980","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1002\/ijc.27552","article-title":"The metastatic microenvironment: brain-derived soluble factors alter the malignant phenotype of cutaneous and brain-metastasizing melanoma cells","volume":"131","author":"Klein","year":"2012","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.semcancer.2021.12.009_bib0985","doi-asserted-by":"crossref","first-page":"2480","DOI":"10.3389\/fimmu.2018.02480","article-title":"Targeting chemokines and chemokine receptors in melanoma and other cancers","volume":"9","author":"Jacquelot","year":"2018","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.semcancer.2021.12.009_bib0990","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/s12943-018-0854-5","article-title":"Deciphering mechanisms of brain metastasis in melanoma - the gist of the matter","volume":"17","author":"Redmer","year":"2018","journal-title":"Mol. Cancer"},{"issue":"30","key":"10.1016\/j.semcancer.2021.12.009_bib0995","doi-asserted-by":"crossref","first-page":"47637","DOI":"10.18632\/oncotarget.10256","article-title":"CCR4 promotes metastasis via ERK\/NF-kappaB\/MMP13 pathway and acts downstream of TNF-alpha in colorectal cancer","volume":"7","author":"Ou","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.semcancer.2021.12.009_bib1000","doi-asserted-by":"crossref","first-page":"379","DOI":"10.3389\/fimmu.2019.00379","article-title":"Chemokines and Chemokine Receptors: New Targets for Cancer Immunotherapy","volume":"10","author":"Mollica Poeta","year":"2019","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.semcancer.2021.12.009_bib1005","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20010096","article-title":"Chemokines and Chemokine Receptors: Orchestrating Tumor Metastasization","volume":"20","author":"Marcuzzi","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.semcancer.2021.12.009_bib1010","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1007\/s10555-010-9256-x","article-title":"CXCL12 \/ CXCR4 \/ CXCR7 chemokine axis and cancer progression","volume":"29","author":"Sun","year":"2010","journal-title":"Cancer Metastasis Rev."},{"issue":"3","key":"10.1016\/j.semcancer.2021.12.009_bib1015","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1158\/0008-5472.967.65.3","article-title":"Silencing of CXCR4 blocks breast cancer metastasis","volume":"65","author":"Liang","year":"2005","journal-title":"Cancer Res."},{"issue":"5","key":"10.1016\/j.semcancer.2021.12.009_bib1020","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1016\/j.ymthe.2018.02.030","article-title":"A chimeric antibody against ACKR3\/CXCR7 in combination with TMZ activates immune responses and extends survival in mouse GBM models","volume":"26","author":"Salazar","year":"2018","journal-title":"Mol. Ther."},{"issue":"7","key":"10.1016\/j.semcancer.2021.12.009_bib1025","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.4161\/cbt.7.7.6065","article-title":"A critical role of CCR7 in invasiveness and metastasis of SW620 colon cancer cell in vitro and in vivo","volume":"7","author":"Yu","year":"2008","journal-title":"Cancer Biol. Ther."},{"issue":"10","key":"10.1016\/j.semcancer.2021.12.009_bib1030","first-page":"12533","article-title":"Silencing of CCR7 inhibits the growth, invasion and migration of prostate cancer cells induced by VEGFC","volume":"8","author":"Chi","year":"2015","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"10.1016\/j.semcancer.2021.12.009_bib1035","article-title":"The CXCL12\/CXCR4\/ACKR3 Axis in the tumor microenvironment: signaling, crosstalk, and therapeutic targeting","author":"Smit","year":"2020","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"issue":"3","key":"10.1016\/j.semcancer.2021.12.009_bib1040","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1021\/jm901530b","article-title":"Synthesis and structure-activity relationships of azamacrocyclic C-X-C chemokine receptor 4 antagonists: analogues containing a single azamacrocyclic ring are potent inhibitors of T-cell tropic (X4) HIV-1 replication","volume":"53","author":"Bridger","year":"2010","journal-title":"J. Med. Chem."},{"issue":"6","key":"10.1016\/j.semcancer.2021.12.009_bib1045","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/S1470-2045(18)30147-5","article-title":"Balixafortide plus eribulin in HER2-negative metastatic breast cancer: a phase 1, single-arm, dose-escalation trial","volume":"19","author":"Pernas","year":"2018","journal-title":"Lancet Oncol."},{"issue":"1","key":"10.1016\/j.semcancer.2021.12.009_bib1050","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1007\/s13346-010-0009-8","article-title":"Intravitreal poly(L-lactide) microparticles sustain retinal and choroidal delivery of TG-0054, a hydrophilic drug intended for neovascular diseases","volume":"1","author":"Shelke","year":"2011","journal-title":"Drug Deliv. Transl. Res."},{"issue":"8","key":"10.1016\/j.semcancer.2021.12.009_bib1055","doi-asserted-by":"crossref","first-page":"3376","DOI":"10.1021\/jm100073m","article-title":"Discovery of novel small molecule orally bioavailable C-X-C chemokine receptor 4 antagonists that are potent inhibitors of T-tropic (X4) HIV-1 replication","volume":"53","author":"Skerlj","year":"2010","journal-title":"J. Med. Chem."},{"issue":"6","key":"10.1016\/j.semcancer.2021.12.009_bib1060","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/j.bbmt.2018.01.039","article-title":"Plerixafor plus granulocyte colony-stimulating factor for patients with non-hodgkin lymphoma and multiple myeloma: long-term follow-up report","volume":"24","author":"Micallef","year":"2018","journal-title":"Biol. Blood Marrow Transplant."},{"issue":"1","key":"10.1016\/j.semcancer.2021.12.009_bib1065","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.canlet.2015.02.005","article-title":"VEGFR inhibitors upregulate CXCR4 in VEGF receptor-expressing glioblastoma in a TGFbetaR signaling-dependent manner","volume":"360","author":"Pham","year":"2015","journal-title":"Cancer Lett."},{"issue":"2","key":"10.1016\/j.semcancer.2021.12.009_bib1070","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1158\/0008-5472.CAN-06-2762","article-title":"Blocking CXCR4-mediated cyclic AMP suppression inhibits brain tumor growth in vivo","volume":"67","author":"Yang","year":"2007","journal-title":"Cancer Res."},{"issue":"2","key":"10.1016\/j.semcancer.2021.12.009_bib1075","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1158\/1535-7163.MCT-14-0850","article-title":"Identification of LY2510924, a novel cyclic peptide CXCR4 antagonist that exhibits antitumor activities in solid tumor and breast cancer metastatic models","volume":"14","author":"Peng","year":"2015","journal-title":"Mol. Cancer Ther."},{"issue":"3","key":"10.1016\/j.semcancer.2021.12.009_bib1080","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0058426","article-title":"The CXCR4 antagonist AMD3465 regulates oncogenic signaling and invasiveness in vitro and prevents breast cancer growth and metastasis in vivo","volume":"8","author":"Ling","year":"2013","journal-title":"PLoS One"},{"issue":"13","key":"10.1016\/j.semcancer.2021.12.009_bib1085","doi-asserted-by":"crossref","first-page":"3581","DOI":"10.1158\/1078-0432.CCR-13-2686","article-title":"A phase I trial of LY2510924, a CXCR4 peptide antagonist, in patients with advanced cancer","volume":"20","author":"Galsky","year":"2014","journal-title":"Clin. Cancer Res."},{"issue":"6","key":"10.1016\/j.semcancer.2021.12.009_bib1090","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1124\/mol.119.116954","article-title":"Antibodies targeting chemokine receptors CXCR4 and ACKR3","volume":"96","author":"Bobkov","year":"2019","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.semcancer.2021.12.009_bib1095","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.bcp.2018.10.014","article-title":"Nanobody-Fc constructs targeting chemokine receptor CXCR4 potently inhibit signaling and CXCR4-mediated HIV-entry and induce antibody effector functions","volume":"158","author":"Bobkov","year":"2018","journal-title":"Biochem. Pharmacol."},{"issue":"9","key":"10.1016\/j.semcancer.2021.12.009_bib1100","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1084\/jem.20052144","article-title":"A novel chemokine receptor for SDF-1 and I-TAC involved in cell survival, cell adhesion, and tumor development","volume":"203","author":"Burns","year":"2006","journal-title":"J. Exp. Med."},{"issue":"6","key":"10.1016\/j.semcancer.2021.12.009_bib1105","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1038\/bjc.2013.482","article-title":"CXCR7-mediated progression of osteosarcoma in the lungs","volume":"109","author":"Goguet-Surmenian","year":"2013","journal-title":"Br. J. Cancer"},{"issue":"10","key":"10.1016\/j.semcancer.2021.12.009_bib1110","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1002\/ijc.31237","article-title":"Enzalutamide and CXCR7 inhibitor combination treatment suppresses cell growth and angiogenic signaling in castration-resistant prostate cancer models","volume":"142","author":"Luo","year":"2018","journal-title":"Int. J. Cancer"},{"issue":"1","key":"10.1016\/j.semcancer.2021.12.009_bib1115","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1158\/1541-7786.MCR-18-0412","article-title":"Targeting the MIF\/CXCR7\/AKT signaling pathway in castration-resistant prostate Cancer","volume":"17","author":"Rafiei","year":"2019","journal-title":"Mol. Cancer Res."},{"issue":"5","key":"10.1016\/j.semcancer.2021.12.009_bib1120","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1038\/bjc.2013.830","article-title":"Inhibition of CXCR7 extends survival following irradiation of brain tumours in mice and rats","volume":"110","author":"Walters","year":"2014","journal-title":"Br. J. Cancer"},{"issue":"4","key":"10.1016\/j.semcancer.2021.12.009_bib1125","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1189\/jlb.0208088","article-title":"A crosstalk between intracellular CXCR7 and CXCR4 involved in rapid CXCL12-triggered integrin activation but not in chemokine-triggered motility of human T lymphocytes and CD34+ cells","volume":"84","author":"Hartmann","year":"2008","journal-title":"J. Leukoc. Biol."},{"issue":"11","key":"10.1016\/j.semcancer.2021.12.009_bib1130","doi-asserted-by":"crossref","first-page":"12344","DOI":"10.18632\/oncotarget.7111","article-title":"A fully human CXCR4 antibody demonstrates diagnostic utility and therapeutic efficacy in solid tumor xenografts","volume":"7","author":"Azad","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.semcancer.2021.12.009_bib1135","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.mce.2019.01.021","article-title":"Nanobodies: New avenues for imaging, stabilizing and modulating GPCRs","volume":"484","author":"De Groof","year":"2019","journal-title":"Mol. Cell. Endocrinol."},{"issue":"1","key":"10.1016\/j.semcancer.2021.12.009_bib1140","doi-asserted-by":"crossref","first-page":"R14","DOI":"10.1186\/bcr3098","article-title":"MicroRNA let-7a suppresses breast cancer cell migration and invasion through downregulation of C-C chemokine receptor type 7","volume":"14","author":"Kim","year":"2012","journal-title":"Breast Cancer Res."},{"issue":"Pt 16","key":"10.1016\/j.semcancer.2021.12.009_bib1145","doi-asserted-by":"crossref","first-page":"2759","DOI":"10.1242\/jcs.029074","article-title":"Distinct motifs in the chemokine receptor CCR7 regulate signal transduction, receptor trafficking and chemotaxis","volume":"121","author":"Otero","year":"2008","journal-title":"J. Cell. Sci."},{"issue":"1","key":"10.1016\/j.semcancer.2021.12.009_bib1150","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1084\/jem.191.1.61","article-title":"The CC chemokine thymus-derived chemotactic agent 4 (TCA-4, secondary lymphoid tissue chemokine, 6Ckine, exodus-2) triggers lymphocyte function-associated antigen 1-mediated arrest of rolling T lymphocytes in peripheral lymph node high endothelial venules","volume":"191","author":"Stein","year":"2000","journal-title":"J. Exp. Med."},{"issue":"8","key":"10.1016\/j.semcancer.2021.12.009_bib1155","doi-asserted-by":"crossref","first-page":"2891","DOI":"10.1158\/1078-0432.CCR-03-0380","article-title":"Intratumoral administration of dendritic cells overexpressing CCL21 generates systemic antitumor responses and confers tumor immunity","volume":"10","author":"Yang","year":"2004","journal-title":"Clin. Cancer Res."},{"issue":"3","key":"10.1016\/j.semcancer.2021.12.009_bib1160","doi-asserted-by":"crossref","DOI":"10.4161\/2162402X.2014.990767","article-title":"Cancer stem cell vaccine inhibits metastases of primary tumors and induces humoral immune responses against cancer stem cells","volume":"4","author":"Lu","year":"2015","journal-title":"Oncoimmunology"},{"issue":"3","key":"10.1016\/j.semcancer.2021.12.009_bib1165","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1158\/0008-5472.CAN-12-2731","article-title":"Targeting tumor-infiltrating macrophages decreases tumor-initiating cells, relieves immunosuppression, and improves chemotherapeutic responses","volume":"73","author":"Mitchem","year":"2013","journal-title":"Cancer Res."},{"issue":"3","key":"10.1016\/j.semcancer.2021.12.009_bib1170","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1158\/2326-6066.CIR-16-0125","article-title":"Macropinocytosis of nab-paclitaxel drives macrophage activation in pancreatic Cancer","volume":"5","author":"Cullis","year":"2017","journal-title":"Cancer Immunol. Res."},{"issue":"5","key":"10.1016\/j.semcancer.2021.12.009_bib1175","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/S1470-2045(16)00078-4","article-title":"Targeting tumour-associated macrophages with CCR2 inhibition in combination with FOLFIRINOX in patients with borderline resectable and locally advanced pancreatic cancer: a single-centre, open-label, dose-finding, non-randomised, phase 1b trial","volume":"17","author":"Nywening","year":"2016","journal-title":"Lancet Oncol."},{"issue":"1","key":"10.1016\/j.semcancer.2021.12.009_bib1180","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1136\/gutjnl-2015-310514","article-title":"Targeting of tumour-infiltrating macrophages via CCL2\/CCR2 signalling as a therapeutic strategy against hepatocellular carcinoma","volume":"66","author":"Li","year":"2017","journal-title":"Gut"},{"key":"10.1016\/j.semcancer.2021.12.009_bib1185","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ebiom.2017.07.014","article-title":"A natural CCR2 antagonist relieves tumor-associated macrophage-mediated immunosuppression to produce a therapeutic effect for liver Cancer","volume":"22","author":"Yao","year":"2017","journal-title":"EBioMedicine"},{"issue":"7525","key":"10.1016\/j.semcancer.2021.12.009_bib1190","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/nature13862","article-title":"Cessation of CCL2 inhibition accelerates breast cancer metastasis by promoting angiogenesis","volume":"515","author":"Bonapace","year":"2014","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.semcancer.2021.12.009_bib1195","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1158\/1078-0432.CCR-16-0870","article-title":"Tumor-derived CCL2 mediates resistance to radiotherapy in pancreatic ductal adenocarcinoma","volume":"23","author":"Kalbasi","year":"2017","journal-title":"Clin. Cancer Res."},{"issue":"2","key":"10.1016\/j.semcancer.2021.12.009_bib1200","doi-asserted-by":"crossref","first-page":"OF1","DOI":"10.1158\/2159-8290.CD-NB2018-001","article-title":"Mogamulizumab tops standard of care for CTCL","volume":"8","year":"2018","journal-title":"Cancer Discov."},{"issue":"5","key":"10.1016\/j.semcancer.2021.12.009_bib1205","doi-asserted-by":"crossref","first-page":"e211","DOI":"10.3324\/haematol.2017.184564","article-title":"Outcomes of patients with relapsed aggressive adult T-cell leukemia-lymphoma: clinical effectiveness of anti-CCR4 antibody and allogeneic hematopoietic stem cell transplantation","volume":"103","author":"Fuji","year":"2018","journal-title":"Haematologica"},{"issue":"9","key":"10.1016\/j.semcancer.2021.12.009_bib1210","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1002\/ajh.24794","article-title":"Chimeric antigen receptor modified T cells that target chemokine receptor CCR4 as a therapeutic modality for T-cell malignancies","volume":"92","author":"Perera","year":"2017","journal-title":"Am. J. Hematol."},{"issue":"3","key":"10.1016\/j.semcancer.2021.12.009_bib1215","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1172\/JCI82976","article-title":"A CCR4 antagonist reverses the tumor-promoting microenvironment of renal cancer","volume":"127","author":"Berlato","year":"2017","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.semcancer.2021.12.009_bib1220","doi-asserted-by":"crossref","first-page":"70","DOI":"10.21037\/sci.2016.09.13","article-title":"Friend or foe? Mogamulizumab in allogeneic hematopoietic stem cell transplantation for adult T-cell leukemia\/lymphoma","volume":"3","author":"Fuji","year":"2016","journal-title":"Stem Cell Investig."},{"issue":"11","key":"10.1016\/j.semcancer.2021.12.009_bib1225","doi-asserted-by":"crossref","first-page":"3008","DOI":"10.1002\/ijc.31842","article-title":"Rapalog combined with CCR4 antagonist improves anticancer vaccines efficacy","volume":"143","author":"Beziaud","year":"2018","journal-title":"Int. J. Cancer"},{"issue":"9","key":"10.1016\/j.semcancer.2021.12.009_bib1230","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/nri3049","article-title":"Homeostatic chemokine receptors and organ-specific metastasis","volume":"11","author":"Zlotnik","year":"2011","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.semcancer.2021.12.009_bib1235","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/170381","article-title":"Chemokines in cancer development and progression and their potential as targeting molecules for cancer treatment","volume":"2014","author":"Mukaida","year":"2014","journal-title":"Mediators Inflamm."},{"issue":"11","key":"10.1016\/j.semcancer.2021.12.009_bib1240","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1096\/fj.03-0935fje","article-title":"Role of high expression levels of CXCR4 in tumor growth, vascularization, and metastasis","volume":"18","author":"Darash-Yahana","year":"2004","journal-title":"FASEB J."},{"issue":"4","key":"10.1016\/j.semcancer.2021.12.009_bib1245","first-page":"291","article-title":"The importance of the CXCL12-CXCR4 chemokine ligand-receptor interaction in prostate cancer metastasis","volume":"4","author":"Arya","year":"2004","journal-title":"J. Exp. Ther. Oncol."},{"key":"10.1016\/j.semcancer.2021.12.009_bib1250","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.cytogfr.2016.08.002","article-title":"The CXCL8-CXCR1\/2 pathways in cancer","volume":"31","author":"Liu","year":"2016","journal-title":"Cytokine Growth Factor Rev."},{"issue":"7","key":"10.1016\/j.semcancer.2021.12.009_bib1255","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1038\/s41419-018-0745-0","article-title":"CXCR1\/Akt signaling activation induced by mesenchymal stem cell-derived IL-8 promotes osteosarcoma cell anoikis resistance and pulmonary metastasis","volume":"9","author":"Du","year":"2018","journal-title":"Cell Death Dis."},{"issue":"6","key":"10.1016\/j.semcancer.2021.12.009_bib1260","first-page":"436","article-title":"CXCR1\/2 chemokine network regulates melanoma resistance to chemotherapies mediated by NF-kappaB","volume":"17","author":"Wu","year":"2017","journal-title":"Curr. Mol. Med."},{"issue":"3","key":"10.1016\/j.semcancer.2021.12.009_bib1265","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1042\/BJ20071493","article-title":"Chemokines and cancer: migration, intracellular signalling and intercellular communication in the microenvironment","volume":"409","author":"O\u2019Hayre","year":"2008","journal-title":"Biochem. J."},{"issue":"4","key":"10.1016\/j.semcancer.2021.12.009_bib1270","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1002\/(SICI)1096-9896(199912)189:4<546::AID-PATH487>3.0.CO;2-L","article-title":"Expression of interleukin-8 detected by in situ hybridization correlates with worse prognosis in primary cutaneous melanoma","volume":"189","author":"Nurnberg","year":"1999","journal-title":"J. Pathol."},{"issue":"3","key":"10.1016\/j.semcancer.2021.12.009_bib1275","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1097\/00008390-199506000-00006","article-title":"Serum interleukin-8 (IL-8) is elevated in patients with metastatic melanoma and correlates with tumour load","volume":"5","author":"Scheibenbogen","year":"1995","journal-title":"Melanoma Res."},{"issue":"8","key":"10.1016\/j.semcancer.2021.12.009_bib1280","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1158\/1541-7786.MCR-07-2108","article-title":"Chemokine decoy receptor d6 plays a negative role in human breast cancer","volume":"6","author":"Wu","year":"2008","journal-title":"Mol. Cancer Res."},{"issue":"11","key":"10.1016\/j.semcancer.2021.12.009_bib1285","doi-asserted-by":"crossref","first-page":"4010","DOI":"10.1158\/0008-5472.CAN-03-1757","article-title":"Pivotal role of CXCR3 in melanoma cell metastasis to lymph nodes","volume":"64","author":"Kawada","year":"2004","journal-title":"Cancer Res."},{"issue":"3","key":"10.1016\/j.semcancer.2021.12.009_bib1290","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1158\/1535-7163.MCT-08-0485","article-title":"CXCR3 expression is associated with poor survival in breast cancer and promotes metastasis in a murine model","volume":"8","author":"Ma","year":"2009","journal-title":"Mol. Cancer Ther."},{"issue":"2","key":"10.1016\/j.semcancer.2021.12.009_bib1295","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.canlet.2008.04.050","article-title":"The role of CXC chemokines and their receptors in cancer","volume":"267","author":"Vandercappellen","year":"2008","journal-title":"Cancer Lett."},{"issue":"55","key":"10.1016\/j.semcancer.2021.12.009_bib1300","doi-asserted-by":"crossref","first-page":"94591","DOI":"10.18632\/oncotarget.21813","article-title":"C-C motif chemokine receptor 1 (CCR1) is a target of the EGF-AKT-mTOR-STAT3 signaling axis in breast cancer cells","volume":"8","author":"Shin","year":"2017","journal-title":"Oncotarget"},{"issue":"3","key":"10.1016\/j.semcancer.2021.12.009_bib1305","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1007\/s10549-011-1502-6","article-title":"The chemokine receptor CCR4 promotes tumor growth and lung metastasis in breast cancer","volume":"131","author":"Li","year":"2012","journal-title":"Breast Cancer Res. Treat."},{"issue":"10","key":"10.1016\/j.semcancer.2021.12.009_bib1310","doi-asserted-by":"crossref","first-page":"e1484980","DOI":"10.1080\/2162402X.2018.1484980","article-title":"Impact of chemotactic factors and receptors on the cancer immune infiltrate: a bioinformatics study revealing homogeneity and heterogeneity among patient cohorts","volume":"7","author":"Stoll","year":"2018","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.semcancer.2021.12.009_bib1315","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1186\/s12943-015-0394-1","article-title":"The chemokine receptor CCR6 facilitates the onset of mammary neoplasia in the MMTV-PyMT mouse model via recruitment of tumor-promoting macrophages","volume":"14","author":"Boyle","year":"2015","journal-title":"Mol. Cancer"},{"issue":"2","key":"10.1016\/j.semcancer.2021.12.009_bib1320","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1002\/ijc.11063","article-title":"Overexpression of CCR7 mRNA in nonsmall cell lung cancer: correlation with lymph node metastasis","volume":"105","author":"Takanami","year":"2003","journal-title":"Int. J. Cancer"},{"issue":"3","key":"10.1016\/j.semcancer.2021.12.009_bib1325","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1158\/1078-0432.CCR-07-2025","article-title":"Activation of CCR9\/CCL25 in cutaneous melanoma mediates preferential metastasis to the small intestine","volume":"14","author":"Amersi","year":"2008","journal-title":"Clin. Cancer Res."},{"issue":"2","key":"10.1016\/j.semcancer.2021.12.009_bib1330","first-page":"373","article-title":"Expression and histopathological correlation of CCR9 and CCL25 in ovarian cancer","volume":"39","author":"Singh","year":"2011","journal-title":"Int. J. Oncol."},{"issue":"3","key":"10.1016\/j.semcancer.2021.12.009_bib1335","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.molmed.2010.01.003","article-title":"Chemokines and chemokine receptors: new insights into cancer-related inflammation","volume":"16","author":"Lazennec","year":"2010","journal-title":"Trends Mol. Med."},{"issue":"9","key":"10.1016\/j.semcancer.2021.12.009_bib1340","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1038\/bjc.2013.565","article-title":"Early expression of the fractalkine receptor CX3CR1 in pancreatic carcinogenesis","volume":"109","author":"Celesti","year":"2013","journal-title":"Br. J. Cancer"},{"issue":"21","key":"10.1016\/j.semcancer.2021.12.009_bib1345","doi-asserted-by":"crossref","first-page":"9060","DOI":"10.1158\/0008-5472.CAN-08-1810","article-title":"The chemokine receptor CX3CR1 is involved in the neural tropism and malignant behavior of pancreatic ductal adenocarcinoma","volume":"68","author":"Marchesi","year":"2008","journal-title":"Cancer Res."},{"issue":"8","key":"10.1016\/j.semcancer.2021.12.009_bib1350","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1038\/nbt1323","article-title":"Tumor refractoriness to anti-VEGF treatment is mediated by CD11b+Gr1+ myeloid cells","volume":"25","author":"Shojaei","year":"2007","journal-title":"Nat. Biotechnol."},{"issue":"14","key":"10.1016\/j.semcancer.2021.12.009_bib1355","doi-asserted-by":"crossref","first-page":"4693","DOI":"10.1158\/0008-5472.CAN-03-3437","article-title":"CX3CR1-fractalkine expression regulates cellular mechanisms involved in adhesion, migration, and survival of human prostate cancer cells","volume":"64","author":"Shulby","year":"2004","journal-title":"Cancer Res."},{"issue":"6","key":"10.1016\/j.semcancer.2021.12.009_bib1360","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1093\/annonc\/mdl053","article-title":"Expression of chemokine receptors predicts the site of metastatic relapse in patients with axillary node positive primary breast cancer","volume":"17","author":"Andre","year":"2006","journal-title":"Ann. Oncol."},{"issue":"5","key":"10.1016\/j.semcancer.2021.12.009_bib1365","doi-asserted-by":"crossref","first-page":"3204","DOI":"10.4049\/jimmunol.0900269","article-title":"Elucidation of CXCR7-mediated signaling events and inhibition of CXCR4-mediated tumor cell transendothelial migration by CXCR7 ligands","volume":"183","author":"Zabel","year":"2009","journal-title":"J. Immunol."}],"container-title":["Seminars in Cancer Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044579X21003023?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044579X21003023?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T00:30:29Z","timestamp":1760920229000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1044579X21003023"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":273,"alternative-id":["S1044579X21003023"],"URL":"https:\/\/doi.org\/10.1016\/j.semcancer.2021.12.009","relation":{},"ISSN":["1044-579X"],"issn-type":[{"value":"1044-579X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rethinking the chemokine cascade in brain metastasis: Preventive and therapeutic implications","name":"articletitle","label":"Article Title"},{"value":"Seminars in Cancer Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semcancer.2021.12.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}